Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer

Helicobacter pylori (H. pylori) is a major causative agent of chronic gastritis, gastric ulcer and gastric carcinoma. H. pylori cytotoxin associated antigen A (CagA) plays a crucial role in the development of gastric cancer. Gastric cancer is associated with glycosylation alterations in glycoproteins and glycolipids on the cell surface. H. pylori cytotoxin associated antigen A (CagA) plays a significant role in the progression of gastric cancer through post-translation modification of fucosylation to develop gastric cancer. The involvement of a variety of sugar antigens in the progression and development of gastric cancer has been investigated, including type II blood group antigens. Lewis Y (LeY) is overexpressed on the tumor cell surface either as a glycoprotein or glycolipid. LeY is a difucosylated oligosaccharide, which is catalyzed by fucosyltransferases such as FUT4 (alpha 1,3). FUT4/LeY overex-pression may serve as potential correlative biomarkers for the prognosis of gastric cancer. We discuss the various aspects of H. pylori in relation to fucosyltransferases (FUT1-FUT9) and its fucosylated Lewis antigens (LeY, LeX, LeA, and LeB) and gastric cancer. In this review, we summarize the carcinogenic effect of H. pylori CagA in association with Le(Y) and its synthesis enzyme FUN in the development of gastric cancer as well as discuss its importance in the prognosis and its inhibition by combination therapy of anti-Le(Y) antibody and celecoxib through MAPK signaling pathway preventing gastric carcinogenesis. (C) 2021 Elsevier Inc. All rights reserved.

Automated summary

Helicobacter pylori and its cytotoxin associated antigen A play significant roles in the development of gastric cancer. Glycosylation alterations and overexpression of Lewis Y may serve as potential biomarkers for the prognosis of gastric cancer.